HALDA THERAPEUTICS, LLC

Profile

Company Names

HALDA THERAPEUTICS, LLC

Addresses

115 MUNSON STREET, SUITE 101, NEW HAVEN, CT 06511

470 JAMES STREET, SUITE 007, NEW HAVEN, CT 06513

Phone Numbers

8606558653

 

Entity Type:

LIMITED LIABILITY COMPANY

Industry:

OTHER HEALTH CARE, BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$197,923,738.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2024-07-31 
$126,471,316.00 
$126,471,316.00 
$0.00 
Equity 
3
2024-05-21 
$24,211,678.00 
$36,000,000.00 
$11,788,322.00 
Debt 
2
2021-12-01 
$40,990,001.00 
$51,000,000.00 
$10,009,999.00 
Equity 
1
2019-02-22 
$6,250,743.00 
$25,150,000.00 
$18,899,257.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JOE 
 
CABRAL 
DIRECTOR
HALDA THERAPEUTICS, LLC   |  LAND MEDICINE INC.
REBECCA 
 
FREY 
DIRECTOR
HALDA THERAPEUTICS, LLC   |  SIDUMA THERAPEUTICS, INC.
ARJUN 
 
GOYAL 
DIRECTOR
VIDA VENTURES, LLC   |  VVAG SPECIAL FUND LLC   |  VIDA VENTURES II, LLC   |  VIDA VENTURES II-A, LLC   |  SCORPION THERAPEUTICS, INC.   |  QUANTA THERAPEUTICS, INC.   |  ALTEROME THERAPEUTICS, INC.   |  THIRD ARC BIO, INC.   |  HALDA THERAPEUTICS, LLC   |  AFFINI-T THERAPEUTICS, INC.
REBECCA 
 
LUSE 
DIRECTOR
LB PHARMACEUTICALS INC   |  HALDA THERAPEUTICS, LLC   |  IMBRIA PHARMACEUTICALS, INC.
SCOTT 
 
PHILLIPS 
EXECUTIVE OFFICER
LATIMER LIGHT PARTNERS LP   |  SENIOR LIVING FUND III CALIFORNIA, LLC   |  HALDA THERAPEUTICS, LLC   |  LAVACA CAPITAL PARTNERS I, LP   |  CAROLINA OIL + GAS FUND LLC   |  PSILOTEC HEALTH SOLUTIONS INC.   |  LAVACA CAPITAL CONVEXITY FUND, LP   |  LAVACA CONVEXITY OFFSHORE FUND   |  JPHC LLC   |  NORMUNITY HOLDING COMPANY, LLC   |  LAVACA CAPITAL CONVEXITY FUND II, LP   |  LAVACA CAPITAL CONVEXITY FUND III, LP
LIAM 
 
RATCLIFFE 
DIRECTOR
AFFERENT PHARMACEUTICALS, INC.   |  NEURONETICS, INC.   |  UNUM THERAPEUTICS, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEW LEAF GROWTH FUND I, L.P.   |  APTINYX INC.   |  CURASEN THERAPEUTICS, INC.   |  ARVINAS, INC.   |  ELIEM THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
NANDITA 
 
SHANGARI 
DIRECTOR
TSCAN THERAPEUTICS, INC.   |  MEDIAR THERAPEUTICS, INC.   |  CAPSTAN THERAPEUTICS, INC.   |  HALDA THERAPEUTICS, LLC
TIM 
 
SHANNON 
EXECUTIVE OFFICER, DIRECTOR
NOVIRA THERAPEUTICS, INC.   |  ARVINAS, INC.   |  CIVITAS THERAPEUTICS, INC.   |  CYTOMX THERAPEUTICS, INC.   |  VIVACE THERAPEUTICS, INC.   |  SPYRYX BIOSCIENCES, INC.   |  ARVINAS HOLDING COMPANY, LLC   |  NEXTCURE, INC.   |  HALDA THERAPEUTICS, LLC   |  RALLYBIO HOLDINGS, LLC   |  CAPITAL INTEGRATION SYSTEMS LLC   |  AER THERAPEUTICS, INC.
LEYI 
 
WANG 
DIRECTOR
HALDA THERAPEUTICS, LLC
WEI 
 
ZHAO 
DIRECTOR
HALDA THERAPEUTICS, LLC   |  ENKEFALOS BIOSCIENCES, INC.   |  FIERA CAPITAL INFRASTRUCTURE FUND SERIES - A SERIES OF FIERA CAPITAL PRIVATE ALTERNATIVES SERIES LP   |  GLOBAL EQUITY LONG-ONLY FUND LP   |  INTERNATIONAL EQUITY LONG-ONLY FUND LP   |  INTERNATIONAL EQUITY LONG-ONLY FUND LP - SERIES E   |  FIERA GLOBAL DIVERSIFIED LENDING FUND, L.P.   |  FIERA CAPITAL PRIVATE ALTERNATIVES SERIES LP - FIERA CAPITAL AGRICULTURE FUND SERIES   |  FIERA CAPITAL PRIVATE ALTERNATIVES SERIES LP - FIERA INFRASTRUCTURE FUND SERIES
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-08-12
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2024-07-31 
2024-05-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2024-05-21 
2021-12-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-12-01 
2019-03-01
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2019-02-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#